N-[(1R)-5-(1,1-Dimethylethyl)-2,3-dihydro-1H-inden-1-yl]-N'-1H-indazol-4-ylurea;ABT-102;1-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]-3-(1H-indazol-4-yl)urea;N-(5-tert-Butylindan-1-yl)-N'-(1H-indazol-4-yl)urea;ABT-102
(ABT102);CHEMBL398338;Urea, N-[(1R)-5-(1,1-dimethylethyl)-2,3-dihydro-1H-inden-1-yl]-N'-1H-indazol-4-yl-;ABT 102, 10 mM in DMSO
ABT-102 is a potent and highly selective vanilloid receptor (TRPV1) antagonist; it effectively and reversibly elevates thermal pain thresholds and reduces suprathreshold orofacial/cutaneous thermal pain; it attenuates nociceptive responses in animal models of inflammatory, bone cancer, postoperative, and osteoarthritic pain.